Managed care
Health Care LA, Ipa
Health Care LA, Ipa was paid $10.89M by Medicaid between Jan 2018 and Aug 2021, across 696 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 7.2% of everything it billed.
33Billing provider infoHEALTH CARE LA, IPA
WOODLAND HILLS, CA 91367
WOODLAND HILLS, CA 91367
33aNPI1801929757assigned 03/13/2007
33bProvider typeHealth Maintenance Organization
28Total paid$10.89M
24GClaims1,601,128
24DCodes billed696
24AFirst – last monthJan 2018 – Aug 2021
Compared with peers
Next to other Health Maintenance Organization providers in California
Rank by total paid#20 of 151
Median peer was paid$59K
This provider vs. median184×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 1,056,297 | $5.88M | |
| 2019 | 12,869 | $150K | |
| 2020 | 226,647 | $2.21M | |
| 2021 | 305,315 | $2.65M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 7.2% | 51,323 | 48,469 | $782K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 6.2% | 25,633 | 8,336 | $676K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 5.4% | 8,963 | 1,687 | $585K |
| 99223 | Prolong inpt eval add15 m | 4.5% | 3,381 | 3,093 | $492K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 4.2% | 6,756 | 6,717 | $461K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 4.1% | 184,727 | 168,749 | $446K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 3.8% | 6,499 | 6,169 | $419K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 3.3% | 4,490 | 4,463 | $355K |
| 67028 | Intravitreal injection of a pharmacologic agent | 3.1% | 1,783 | 1,234 | $336K |
| 99232 | Hospital visit by a doctor, follow-up daySubsequent hospital care, per day, moderate complexity | 2.3% | 6,571 | 1,873 | $252K |
| 99233 | Hospital visit by a doctor, follow-up day (complex)Prolong inpt eval add15 m | 1.8% | 4,681 | 1,444 | $194K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 1.6% | 1,404 | 1,379 | $169K |
684 more codes
| 99205 | Prolong outpt/office vis | 1.5% | 1,568 | $159K |
| 92134 | 1.4% | 2,691 | $155K | |
| 99283 | Emergency room visit (moderate) | 1.4% | 5,603 | $149K |
| J9035 | Injection, bevacizumab, 10 mg | 1.3% | 1,657 | $146K |
| 59409 | Vaginal delivery only (with or without episiotomy and/or forceps) | 1.3% | 281 | $145K |
| 76641 | 1.3% | 1,222 | $144K | |
| S9083 | Global fee urgent care centers | 1.3% | 3,660 | $143K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 1.3% | 38,089 | $140K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 1.2% | 35,041 | $135K |
| E1390 | Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate | 1.1% | 1,062 | $123K |
| 99203 | Doctor's office visit, new patient (routine) | 1.1% | 4,182 | $118K |
| 99285 | Emergency room visit (most serious) | 1.1% | 2,333 | $118K |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | <1% | 2,450 | $102K |
| 99284 | Emergency room visit (serious) | <1% | 2,882 | $102K |
| 97039 | <1% | 3,486 | $101K | |
| 95144 | <1% | 2,538 | $101K | |
| 92250 | <1% | 2,392 | $101K | |
| 99309 | Subsequent nursing facility care, per day, low to moderate complexity | <1% | 1,171 | $94K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 8,100 | $92K |
| 99244 | Office or other outpatient consultation, moderate to high complexity | <1% | 1,232 | $88K |
| 92235 | <1% | 1,233 | $87K | |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | <1% | 2,428 | $76K |
| H1001 | Prenatal care, at-risk enhanced service; antepartum management | <1% | 1,634 | $75K |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | <1% | 1,921 | $70K |
| 67500 | <1% | 594 | $69K | |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 785 | $69K |
| 93000 | <1% | 3,054 | $67K | |
| 90960 | End-stage renal disease related services monthly, for patients 20 years and older, with 4 or more face-to-face visits | <1% | 265 | $63K |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 1,208 | $60K |
| 59514 | <1% | 166 | $57K | |
| 97014 | <1% | 5,233 | $52K | |
| 99221 | <1% | 2,766 | $50K | |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | <1% | 590 | $49K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 83,353 | $44K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 3,512 | $43K |
| 97803 | <1% | 2,426 | $42K | |
| 99308 | Subsequent nursing facility care, per day, straightforward | <1% | 973 | $42K |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 2,966 | $39K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 288 | $39K |
| V2020 | Frames, purchases | <1% | 2,172 | $37K |
| 97162 | <1% | 643 | $37K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 652 | $36K |
| T4541 | Incontinence product, disposable underpad, large, each | <1% | 1,154 | $36K |
| 20610 | <1% | 719 | $36K | |
| 76830 | Ultrasound, transvaginal | <1% | 846 | $36K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 921 | $35K |
| 92340 | Fitting of spectacles, except for aphakia; monofocal | <1% | 1,918 | $35K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 6,629 | $35K |
| 97802 | <1% | 2,247 | $35K | |
| 80053 | Comprehensive metabolic panel | <1% | 91,200 | $34K |
| 81025 | <1% | 7,174 | $33K | |
| 76512 | <1% | 500 | $32K | |
| E0601 | Continuous positive airway pressure (cpap) device | <1% | 610 | $31K |
| 67210 | <1% | 162 | $31K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 2,695 | $31K |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | <1% | 630 | $30K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 86 | $30K |
| E0443 | Portable oxygen contents, gaseous, 1 month's supply = 1 unit | <1% | 605 | $29K |
| 99199 | Unlisted special service, procedure or report | <1% | 961 | $28K |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | <1% | 211 | $28K |
| K0001 | Standard wheelchair | <1% | 598 | $27K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 135 | $26K |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 684 | $26K |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 729 | $25K |
| 71045 | Radiologic examination, chest; single view | <1% | 3,503 | $23K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 28,537 | $22K |
| 99241 | <1% | 1,357 | $22K | |
| E0603 | Breast pump, electric (ac and/or dc), any type | <1% | 237 | $22K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,439 | $21K |
| 81000 | <1% | 2,592 | $21K | |
| 20553 | <1% | 521 | $21K | |
| 95117 | <1% | 2,338 | $20K | |
| 99152 | <1% | 198 | $19K | |
| 67228 | <1% | 100 | $19K | |
| 59425 | <1% | 2,502 | $19K | |
| 92015 | Determination of refractive state | <1% | 3,496 | $18K |
| 59025 | Fetal non-stress test | <1% | 711 | $18K |
| A4649 | Surgical supply; miscellaneous | <1% | 786 | $18K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 415 | $18K |
| J3490 | Unclassified drugs | <1% | 1,542 | $17K |
| 96367 | <1% | 131 | $17K | |
| E0431 | Portable gaseous oxygen system, rental; includes portable container, regulator, flowmeter, humidifier, cannula or mask, and tubing | <1% | 824 | $16K |
| 95115 | <1% | 3,494 | $16K | |
| 77066 | Tomosynthesis, mammo | <1% | 169 | $15K |
| T4535 | Disposable liner/shield/guard/pad/undergarment, for incontinence, each | <1% | 479 | $14K |
| 92226 | <1% | 509 | $14K | |
| 99245 | <1% | 123 | $14K | |
| 99153 | Mod sedat endo service >5yrs | <1% | 110 | $13K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 296 | $13K |
| T4522 | Adult sized disposable incontinence product, brief/diaper, medium, each | <1% | 158 | $13K |
| 95004 | Percutaneous tests with allergenic extracts, immediate type reaction | <1% | 127 | $13K |
| 66984 | Extracapsular cataract removal with insertion of intraocular lens prosthesis | <1% | 13 | $13K |
| 93320 | <1% | 150 | $12K | |
| A4267 | Contraceptive supply, condom, male, each | <1% | 565 | $12K |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | <1% | 102 | $12K |
| 92060 | <1% | 398 | $12K | |
| 99239 | Hospital discharge day management, more than 30 minutes | <1% | 245 | $12K |
| 99243 | <1% | 227 | $11K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 13,372 | $11K |
| 77065 | Tomosynthesis, mammo | <1% | 82 | $11K |
| 93970 | <1% | 146 | $11K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 545 | $11K |
| 17380 | <1% | 125 | $10K | |
| Q3014 | Telehealth originating site facility fee | <1% | 266 | $10K |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 806 | $10K |
| A4670 | Automatic blood pressure monitor | <1% | 187 | $10K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 721 | $10K |
| E0570 | Nebulizer, with compressor | <1% | 126 | $10K |
| E0562 | Humidifier, heated, used with positive airway pressure device | <1% | 341 | $9K |
| A4461 | Surgical dressing holder, non-reusable, each | <1% | 334 | $9K |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | <1% | 242 | $9K |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | <1% | 1,248 | $9K |
| E0143 | Walker, folding, wheeled, adjustable or fixed height | <1% | 145 | $9K |
| 76801 | <1% | 232 | $9K | |
| 72275 | <1% | 146 | $9K | |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 34 | $9K |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 27 | $9K |
| T4527 | Adult sized disposable incontinence product, protective underwear/pull-on, large size, each | <1% | 98 | $9K |
| 85730 | <1% | 6,841 | $9K | |
| 93978 | <1% | 93 | $8K | |
| 93325 | <1% | 179 | $8K | |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 402 | $8K |
| 93351 | <1% | 147 | $8K | |
| H1003 | Prenatal care, at-risk enhanced service; education | <1% | 2,291 | $8K |
| 93880 | <1% | 93 | $8K | |
| 11721 | <1% | 484 | $8K | |
| 97161 | <1% | 194 | $8K | |
| 85027 | <1% | 16,413 | $8K | |
| 83861 | <1% | 476 | $7K | |
| 92521 | <1% | 128 | $7K | |
| 97010 | <1% | 1,472 | $7K | |
| 81003 | <1% | 5,595 | $7K | |
| 93976 | <1% | 95 | $7K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 2,411 | $7K |
| 81001 | <1% | 34,072 | $7K | |
| 99000 | <1% | 9,173 | $7K | |
| 80061 | Lipid panel | <1% | 59,979 | $7K |
| 87806 | <1% | 417 | $7K | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 263 | $7K |
| 95819 | <1% | 12 | $6K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 1,623 | $6K |
| 93015 | <1% | 136 | $6K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 44,021 | $6K |
| H1000 | Prenatal care, at-risk assessment | <1% | 155 | $6K |
| 93925 | <1% | 101 | $6K | |
| 95886 | <1% | 51 | $6K | |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 36 | $6K |
| 62323 | <1% | 129 | $6K | |
| 99401 | <1% | 2,531 | $6K | |
| 85610 | <1% | 9,929 | $6K | |
| 99460 | <1% | 139 | $6K | |
| 92133 | <1% | 199 | $6K | |
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 15-21 drug class(es), including metabolite(s) if performed | <1% | 322 | $6K |
| K0553 | Supply allowance for therapeutic continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service | <1% | 27 | $6K |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | <1% | 181 | $6K |
| 94150 | <1% | 1,114 | $6K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 270 | $6K |
| T4523 | Adult sized disposable incontinence product, brief/diaper, large, each | <1% | 48 | $6K |
| 01810 | <1% | 203 | $6K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 59,432 | $5K |
| 68761 | <1% | 94 | $5K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 41 | $5K |
| 92083 | <1% | 201 | $5K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 54,373 | $5K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 15,269 | $5K |
| 83690 | <1% | 4,962 | $5K | |
| T4526 | Adult sized disposable incontinence product, protective underwear/pull-on, medium size, each | <1% | 100 | $5K |
| 83516 | <1% | 806 | $5K | |
| 92020 | <1% | 126 | $5K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 17,442 | $4K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 529 | $4K |
| 81420 | Fetal chromosomal aneuploidy genomic sequence analysis panel | <1% | 12 | $4K |
| 17004 | <1% | 83 | $4K | |
| 84484 | <1% | 3,119 | $4K | |
| 94760 | <1% | 1,509 | $4K | |
| 17110 | <1% | 44 | $4K | |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 112 | $4K |
| 99310 | Prolong nursin fac eval 15m | <1% | 67 | $4K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 14,747 | $4K |
| S9088 | Services provided in an urgent care center (list in addition to code for service) | <1% | 602 | $4K |
| G0283 | Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care | <1% | 678 | $4K |
| A4580 | Cast supplies (e.g., plaster) | <1% | 128 | $4K |
| 76642 | <1% | 64 | $4K | |
| 81002 | <1% | 6,599 | $4K | |
| 72141 | <1% | 12 | $4K | |
| 76819 | Fetal biophysical profile; without non-stress testing | <1% | 61 | $3K |
| 83735 | <1% | 4,599 | $3K | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 45 | $3K |
| 31231 | <1% | 13 | $3K | |
| 73130 | <1% | 106 | $3K | |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed | <1% | 110 | $3K |
| 99335 | <1% | 93 | $3K | |
| A6250 | Skin sealants, protectants, moisturizers, ointments, any type, any size | <1% | 233 | $3K |
| 85018 | <1% | 14,418 | $3K | |
| K0195 | Elevating leg rests, pair (for use with capped rental wheelchair base) | <1% | 165 | $3K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 23,711 | $3K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 45 | $3K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 670 | $3K |
| 99307 | <1% | 160 | $3K | |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 59 | $3K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 108 | $3K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 104 | $3K |
| 73560 | <1% | 85 | $3K | |
| 83880 | <1% | 1,220 | $3K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 863 | $2K |
| 73030 | <1% | 76 | $2K | |
| 80076 | <1% | 3,969 | $2K | |
| 86592 | <1% | 24,869 | $2K | |
| 76770 | <1% | 44 | $2K | |
| 92651 | <1% | 29 | $2K | |
| 88312 | <1% | 64 | $2K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 439 | $2K |
| 93224 | <1% | 27 | $2K | |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 44 | $2K |
| A9575 | Injection, gadoterate meglumine, 0.1 ml | <1% | 30 | $2K |
| R0070 | Transportation of portable x-ray equipment and personnel to home or nursing home, per trip to facility or location, one patient seen | <1% | 13 | $2K |
| 73110 | <1% | 39 | $2K | |
| 85007 | <1% | 3,130 | $2K | |
| 80055 | <1% | 615 | $2K | |
| 73630 | <1% | 76 | $2K | |
| 82728 | <1% | 4,091 | $2K | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 257 | $2K |
| 86901 | <1% | 1,573 | $2K | |
| A4590 | Special casting material (e.g., fiberglass) | <1% | 93 | $2K |
| 3008F | <1% | 10,513 | $2K | |
| 87799 | <1% | 56 | $2K | |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | <1% | 38 | $2K |
| A4335 | Incontinence supply; miscellaneous | <1% | 259 | $2K |
| 90736 | <1% | 137 | $2K | |
| 83550 | <1% | 4,051 | $2K | |
| 77080 | <1% | 100 | $2K | |
| 86003 | <1% | 1,087 | $2K | |
| 86803 | <1% | 11,706 | $2K | |
| A6402 | Gauze, non-impregnated, sterile, pad size 16 sq. in. or less, without adhesive border, each dressing | <1% | 84 | $2K |
| 87481 | <1% | 59 | $2K | |
| 92202 | <1% | 122 | $2K | |
| 82948 | <1% | 4,660 | $2K | |
| 86900 | <1% | 1,584 | $2K | |
| A7035 | Headgear used with positive airway pressure device | <1% | 81 | $2K |
| 82570 | <1% | 10,517 | $2K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 115 | $2K |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 5,805 | $2K |
| Q0144 | Azithromycin dihydrate, oral, capsules/powder, 1 gram | <1% | 13 | $2K |
| 83970 | <1% | 427 | $1K | |
| 10040 | <1% | 55 | $1K | |
| 86769 | <1% | 251 | $1K | |
| 82607 | <1% | 4,097 | $1K | |
| 84702 | <1% | 2,113 | $1K | |
| 88304 | <1% | 104 | $1K | |
| 73562 | <1% | 64 | $1K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 105 | $1K |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 7,677 | $1K |
| 76536 | <1% | 29 | $1K | |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 13 | $1K |
| 93303 | Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study | <1% | 16 | $1K |
| 80305 | <1% | 65 | $1K | |
| 92587 | <1% | 44 | $1K | |
| 15852 | <1% | 46 | $1K | |
| 84439 | <1% | 7,710 | $1K | |
| 73610 | <1% | 41 | $1K | |
| 92557 | <1% | 42 | $1K | |
| 90715 | <1% | 2,438 | $1K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 36 | $1K |
| 82947 | <1% | 5,551 | $1K | |
| 11720 | <1% | 70 | $1K | |
| E0295 | Hospital bed, semi-electric (head and foot adjustment), without side rails, without mattress | <1% | 12 | $1K |
| 97163 | <1% | 25 | $1K | |
| 90670 | <1% | 1,213 | $1K | |
| 87340 | <1% | 5,668 | $1K | |
| 99201 | <1% | 749 | $1K | |
| 86140 | <1% | 2,776 | $1K | |
| 82962 | <1% | 4,259 | $1K | |
| 51798 | <1% | 49 | $1K | |
| G9920 | Screening performed and negative | <1% | 368 | $1K |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | <1% | 26 | $1K |
| 84100 | <1% | 1,779 | $1K | |
| 86850 | <1% | 687 | $1K | |
| 87081 | <1% | 2,289 | $976.23 | |
| 87040 | <1% | 799 | $975.07 | |
| 87088 | <1% | 8,803 | $966.14 | |
| A4217 | Sterile water/saline, 500 ml | <1% | 27 | $949.66 |
| 72100 | <1% | 40 | $921.13 | |
| 99051 | <1% | 135 | $910.07 | |
| S4993 | Contraceptive pills for birth control | <1% | 27 | $902.18 |
| 87186 | <1% | 2,357 | $859.76 | |
| 3074F | <1% | 4,058 | $857.35 | |
| 88307 | <1% | 53 | $844.88 | |
| E0114 | Crutches underarm, other than wood, adjustable or fixed, pair, with pads, tips and handgrips | <1% | 27 | $841.09 |
| 83540 | <1% | 4,829 | $839.47 | |
| E0163 | Commode chair, mobile or stationary, with fixed arms | <1% | 12 | $822.48 |
| 84703 | <1% | 1,159 | $809.02 | |
| 97139 | <1% | 157 | $800.00 | |
| 92586 | <1% | 12 | $789.96 | |
| 11100 | <1% | 12 | $786.38 | |
| 99442 | <1% | 868 | $779.90 | |
| 87070 | <1% | 2,807 | $764.41 | |
| 86235 | <1% | 321 | $715.26 | |
| 83605 | <1% | 408 | $712.85 | |
| 95816 | <1% | 12 | $710.00 | |
| 90686 | <1% | 6,057 | $655.65 | |
| 87522 | Neg quan hep c or qual rna | <1% | 615 | $644.78 |
| T1014 | Telehealth transmission, per minute, professional services bill separately | <1% | 52 | $635.88 |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 3,413 | $631.48 |
| 87077 | <1% | 2,390 | $605.12 | |
| 0760 | <1% | 67 | $594.75 | |
| 11901 | <1% | 41 | $585.91 | |
| A7038 | Filter, disposable, used with positive airway pressure device | <1% | 95 | $577.43 |
| G9551 | Final reports for imaging studies without an incidentally found lesion noted | <1% | 28 | $574.96 |
| 76813 | <1% | 12 | $574.35 | |
| 83615 | <1% | 1,475 | $556.87 | |
| 87210 | <1% | 983 | $550.32 | |
| 90688 | <1% | 1,922 | $544.00 | |
| 82043 | <1% | 10,679 | $538.29 | |
| 82247 | <1% | 453 | $531.36 | |
| 86038 | <1% | 1,736 | $529.65 | |
| V5008 | Hearing screening | <1% | 29 | $518.81 |
| 82652 | <1% | 1,164 | $493.73 | |
| 69210 | <1% | 61 | $485.83 | |
| 76857 | <1% | 13 | $481.80 | |
| 82746 | <1% | 3,013 | $480.76 | |
| 3078F | <1% | 4,093 | $462.81 | |
| 84153 | <1% | 2,504 | $461.47 | |
| 86160 | <1% | 296 | $460.01 | |
| 84481 | <1% | 1,088 | $432.37 | |
| 82550 | <1% | 594 | $418.44 | |
| 59430 | <1% | 28 | $393.89 | |
| 92100 | <1% | 14 | $375.51 | |
| 84403 | <1% | 1,544 | $371.89 | |
| 15851 | <1% | 13 | $336.92 | |
| A7005 | Administration set, with small volume nonfiltered pneumatic nebulizer, non-disposable | <1% | 19 | $335.74 |
| 92341 | <1% | 24 | $333.90 | |
| 82248 | <1% | 3,082 | $330.09 | |
| 83021 | <1% | 309 | $326.47 | |
| 93018 | <1% | 12 | $322.80 | |
| A6216 | Gauze, non-impregnated, non-sterile, pad size 16 sq. in. or less, without adhesive border, each dressing | <1% | 16 | $322.79 |
| 90732 | <1% | 63 | $321.03 | |
| 72040 | <1% | 12 | $312.16 | |
| 85652 | <1% | 4,525 | $298.33 | |
| 81015 | <1% | 576 | $288.50 | |
| 86780 | <1% | 870 | $286.68 | |
| 73221 | <1% | 15 | $282.09 | |
| 96150 | <1% | 152 | $270.36 | |
| 3725F | <1% | 6,243 | $270.21 | |
| 84460 | <1% | 2,244 | $267.85 | |
| 1160F | <1% | 3,831 | $266.00 | |
| 84550 | <1% | 2,441 | $263.72 | |
| 93016 | <1% | 12 | $260.46 | |
| 92081 | <1% | 74 | $255.00 | |
| 82274 | <1% | 3,852 | $246.39 | |
| H0049 | Alcohol and/or drug screening | <1% | 5,367 | $239.22 |
| 80074 | <1% | 1,937 | $237.43 | |
| 83002 | <1% | 706 | $232.52 | |
| 90658 | <1% | 394 | $230.42 | |
| E0971 | Manual wheelchair accessory, anti-tipping device, each | <1% | 13 | $230.05 |
| 86360 | <1% | 76 | $228.18 | |
| 84156 | <1% | 393 | $225.70 | |
| 82565 | <1% | 549 | $225.63 | |
| 83986 | <1% | 44 | $221.26 | |
| 87205 | <1% | 311 | $214.41 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 746 | $212.64 |
| 82120 | <1% | 27 | $211.30 | |
| 86225 | <1% | 413 | $209.74 | |
| Q0092 | Set-up portable x-ray equipment | <1% | 15 | $199.78 |
| 84155 | <1% | 397 | $199.55 | |
| 92551 | <1% | 5,763 | $198.36 | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 1,310 | $197.10 |
| 90723 | <1% | 136 | $197.10 | |
| 82270 | <1% | 379 | $197.10 | |
| 86701 | <1% | 211 | $185.52 | |
| 83498 | <1% | 177 | $166.14 | |
| 82533 | <1% | 90 | $164.64 | |
| 83001 | <1% | 1,113 | $160.70 | |
| 82378 | <1% | 418 | $160.70 | |
| 73080 | <1% | 26 | $156.38 | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 1,613 | $156.00 |
| 80047 | <1% | 53 | $149.10 | |
| 86706 | <1% | 3,049 | $147.39 | |
| 82776 | <1% | 108 | $146.94 | |
| 99406 | <1% | 781 | $144.11 | |
| 1036F | <1% | 2,428 | $144.00 | |
| 84436 | <1% | 1,659 | $142.07 | |
| 82785 | <1% | 770 | $140.28 | |
| 82261 | <1% | 108 | $135.96 | |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | <1% | 449 | $135.92 |
| 85045 | <1% | 306 | $131.63 | |
| 86703 | <1% | 166 | $128.76 | |
| 84450 | <1% | 1,246 | $127.70 | |
| 86762 | <1% | 304 | $120.30 | |
| 83789 | <1% | 111 | $114.93 | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 775 | $114.38 |
| 96900 | <1% | 14 | $113.26 | |
| 99173 | <1% | 13,251 | $112.49 | |
| 86431 | <1% | 1,261 | $111.87 | |
| 99441 | <1% | 360 | $111.76 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 435 | $111.54 |
| 17340 | <1% | 18 | $109.29 | |
| 83655 | <1% | 4,181 | $109.01 | |
| 82670 | <1% | 631 | $107.36 | |
| 86039 | <1% | 305 | $105.00 | |
| 82150 | <1% | 282 | $104.38 | |
| 82105 | <1% | 161 | $101.98 | |
| 92567 | <1% | 46 | $99.19 | |
| 84146 | <1% | 1,024 | $97.58 | |
| 71010 | <1% | 30 | $96.88 | |
| 29540 | <1% | 56 | $96.50 | |
| 88142 | <1% | 2,107 | $87.73 | |
| 80202 | <1% | 136 | $86.81 | |
| 96151 | <1% | 258 | $85.71 | |
| 3044F | <1% | 380 | $84.89 | |
| 87536 | <1% | 2,184 | $84.25 | |
| 84480 | <1% | 413 | $83.23 | |
| 86376 | <1% | 435 | $82.58 | |
| 82553 | <1% | 19 | $79.25 | |
| 80051 | <1% | 211 | $79.06 | |
| 82977 | <1% | 1,145 | $77.75 | |
| 86800 | <1% | 282 | $77.63 | |
| S9445 | Patient education, not otherwise classified, non-physician provider, individual, per session | <1% | 515 | $75.69 |
| 84520 | <1% | 429 | $70.62 | |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | <1% | 2,313 | $70.00 |
| 36416 | <1% | 311 | $68.70 | |
| 80320 | <1% | 78 | $66.82 | |
| 86696 | <1% | 309 | $66.42 | |
| 85651 | <1% | 15 | $66.35 | |
| 90698 | <1% | 364 | $66.15 | |
| 81005 | <1% | 32 | $64.92 | |
| 82803 | <1% | 122 | $63.62 | |
| 86317 | <1% | 1,213 | $63.32 | |
| 82310 | <1% | 222 | $63.14 | |
| 96160 | <1% | 720 | $63.00 | |
| 87209 | <1% | 206 | $62.35 | |
| 86480 | <1% | 2,616 | $61.98 | |
| 90746 | <1% | 254 | $56.21 | |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 3,499 | $53.63 |
| 83013 | <1% | 462 | $53.34 | |
| 3045F | <1% | 313 | $50.00 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 12 | $48.82 |
| 0501F | <1% | 27 | $46.98 | |
| 86695 | <1% | 300 | $45.33 | |
| G2024 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]) from an individual in a snf or by a laboratory on behalf of a hha, any specimen source | <1% | 16 | $44.56 |
| 86765 | <1% | 118 | $44.25 | |
| 83721 | <1% | 156 | $43.72 | |
| 84466 | <1% | 13 | $43.60 | |
| 80197 | <1% | 82 | $42.77 | |
| 80164 | <1% | 32 | $39.13 | |
| 86787 | <1% | 273 | $38.62 | |
| 86304 | <1% | 96 | $37.63 | |
| 82627 | <1% | 316 | $37.20 | |
| 82951 | <1% | 328 | $33.48 | |
| 87177 | <1% | 206 | $30.90 | |
| 86704 | <1% | 3,443 | $29.80 | |
| 84075 | <1% | 116 | $27.70 | |
| 83525 | <1% | 262 | $27.19 | |
| 84133 | <1% | 51 | $26.23 | |
| 80069 | <1% | 436 | $25.11 | |
| 85060 | <1% | 156 | $25.00 | |
| 84479 | <1% | 1,248 | $24.81 | |
| T1003 | Lpn/lvn services, up to 15 minutes | <1% | 4,198 | $24.26 |
| 87075 | <1% | 26 | $23.94 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 105 | $23.75 |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 856 | $23.49 |
| 87905 | <1% | 309 | $23.49 | |
| 87390 | <1% | 227 | $23.49 | |
| 0500F | <1% | 99 | $23.49 | |
| 82465 | <1% | 1,590 | $22.03 | |
| 87338 | <1% | 1,216 | $21.99 | |
| 86300 | <1% | 245 | $21.80 | |
| 80329 | <1% | 83 | $21.71 | |
| 82784 | <1% | 174 | $20.91 | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 26 | $20.28 |
| A7015 | Aerosol mask, used with dme nebulizer | <1% | 14 | $17.03 |
| 82950 | <1% | 1,857 | $15.82 | |
| 85379 | <1% | 13 | $15.61 | |
| 87480 | <1% | 519 | $14.70 | |
| 87510 | <1% | 520 | $14.70 | |
| 87660 | <1% | 515 | $14.43 | |
| 83718 | <1% | 1,054 | $13.16 | |
| 86593 | <1% | 844 | $10.62 | |
| 87147 | <1% | 613 | $9.78 | |
| 83020 | <1% | 138 | $9.47 | |
| 86709 | <1% | 299 | $8.91 | |
| 82040 | <1% | 45 | $7.90 | |
| 85014 | <1% | 277 | $7.09 | |
| 82952 | <1% | 205 | $3.43 | |
| 85041 | <1% | 44 | $2.39 | |
| 86200 | <1% | 594 | $2.10 | |
| 1000F | <1% | 5,265 | $0.08 | |
| 0502F | 0% | 950 | $0.00 | |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 0% | 4,188 | $0.00 |
| 3288F | 0% | 1,115 | $0.00 | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 0% | 2,573 | $0.00 |
| 90734 | 0% | 1,088 | $0.00 | |
| T1015 | A visit at a community health center or clinic (one all-in rate) | 0% | 8,459 | $0.00 |
| 90649 | 0% | 481 | $0.00 | |
| 99001 | 0% | 536 | $0.00 | |
| 3077F | 0% | 224 | $0.00 | |
| 81220 | CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants | 0% | 364 | $0.00 |
| 1159F | 0% | 3,205 | $0.00 | |
| 4004F | 0% | 311 | $0.00 | |
| 98966 | 0% | 517 | $0.00 | |
| 83026 | 0% | 156 | $0.00 | |
| 90461 | 0% | 694 | $0.00 | |
| 90832 | Psychotherapy session, about 30 minutes | 0% | 447 | $0.00 |
| S3645 | Hiv-1 antibody testing of oral mucosal transudate | 0% | 232 | $0.00 |
| 90687 | 0% | 364 | $0.00 | |
| 92552 | 0% | 4,253 | $0.00 | |
| 86708 | 0% | 3,153 | $0.00 | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 0% | 2,930 | $0.00 |
| 90710 | 0% | 403 | $0.00 | |
| 90633 | 0% | 936 | $0.00 | |
| 0450 | Emergency room services | 0% | 162 | $0.00 |
| 0002A | 0% | 1,063 | $0.00 | |
| 90707 | 0% | 288 | $0.00 | |
| 90713 | 0% | 103 | $0.00 | |
| 84445 | 0% | 54 | $0.00 | |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | 0% | 44 | $0.00 |
| 91300 | 0% | 2,380 | $0.00 | |
| 90644 | 0% | 286 | $0.00 | |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 0% | 923 | $0.00 |
| G0444 | Annual depression screening, 5 to 15 minutes | 0% | 1,216 | $0.00 |
| 99404 | 0% | 119 | $0.00 | |
| 90396 | 0% | 63 | $0.00 | |
| 99072 | 0% | 1,086 | $0.00 | |
| G2012 | Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion | 0% | 219 | $0.00 |
| 85613 | 0% | 39 | $0.00 | |
| 98942 | 0% | 191 | $0.00 | |
| 86735 | 0% | 99 | $0.00 | |
| 90700 | 0% | 257 | $0.00 | |
| 90791 | Psychiatric diagnostic evaluation | 0% | 66 | $0.00 |
| G8431 | Screening for depression is documented as being positive and a follow-up plan is documented | 0% | 122 | $0.00 |
| 2028F | 0% | 180 | $0.00 | |
| 3046F | 0% | 214 | $0.00 | |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | 0% | 25 | $0.00 |
| 59426 | 0% | 132 | $0.00 | |
| D0220 | Intraoral - periapical first radiographic image | 0% | 13 | $0.00 |
| P9604 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge | 0% | 293 | $0.00 |
| 99080 | 0% | 49 | $0.00 | |
| G0511 | Rural health clinic or federally qualified health center (rhc or fqhc) only, general care management, 20 minutes or more of clinical staff time for chronic care management services or behavioral health integration services directed by an rhc or fqhc practitioner (physician, np, pa, or cnm), per calendar month | 0% | 56 | $0.00 |
| 87045 | 0% | 86 | $0.00 | |
| 87427 | 0% | 85 | $0.00 | |
| D0190 | 0% | 316 | $0.00 | |
| 86147 | 0% | 55 | $0.00 | |
| 76818 | 0% | 19 | $0.00 | |
| 90681 | 0% | 67 | $0.00 | |
| A4218 | Sterile saline or water, metered dose dispenser, 10 ml | 0% | 76 | $0.00 |
| 90685 | 0% | 31 | $0.00 | |
| H1002 | Prenatal care, at risk enhanced service; care coordination | 0% | 12 | $0.00 |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | 0% | 44 | $0.00 |
| 86689 | 0% | 12 | $0.00 | |
| 86318 | 0% | 21 | $0.00 | |
| 90648 | 0% | 204 | $0.00 | |
| A0425 | Ground mileage, per statute mile | 0% | 42 | $0.00 |
| 98940 | 0% | 17 | $0.00 | |
| 99490 | Ccm add 20min | 0% | 44 | $0.00 |
| 86644 | 0% | 14 | $0.00 | |
| G0459 | Inpatient telehealth pharmacologic management, including prescription, use, and review of medication with no more than minimal medical psychotherapy | 0% | 26 | $0.00 |
| 11056 | 0% | 35 | $0.00 | |
| S0199 | Medically induced abortion by oral ingestion of medication including all associated services and supplies (e.g., patient counseling, office visits, confirmation of pregnancy by hcg, ultrasound to confirm duration of pregnancy, ultrasound to confirm completion of abortion) except drugs | 0% | 12 | $0.00 |
| 82085 | 0% | 47 | $0.00 | |
| 87535 | 0% | 52 | $0.00 | |
| 90672 | 0% | 20 | $0.00 | |
| 90756 | 0% | 40 | $0.00 | |
| 76827 | 0% | 26 | $0.00 | |
| G0127 | Trimming of dystrophic nails, any number | 0% | 12 | $0.00 |
| 90837 | Psychotherapy session, about an hour | 0% | 37 | $0.00 |
| 86328 | 0% | 15 | $0.00 | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 0% | 30 | $0.00 |
| 86705 | 0% | 27 | $0.00 | |
| 3015F | 0% | 56 | $0.00 | |
| 87329 | 0% | 12 | $0.00 | |
| 87631 | 0% | 12 | $0.00 | |
| 0360 | 0% | 12 | $0.00 | |
| 2022F | 0% | 15 | $0.00 | |
| 99188 | 0% | 17 | $0.00 | |
| 98941 | Chiropractic manipulative treatment; spinal, 3-4 regions | 0% | 561 | $0.00 |
| 84999 | 0% | 605 | $0.00 | |
| 1126F | 0% | 669 | $0.00 | |
| 1170F | 0% | 2,103 | $0.00 | |
| G0467 | Community health center visit, returning patient | 0% | 288 | $0.00 |
| 0001A | 0% | 1,356 | $0.00 | |
| 90651 | 0% | 1,445 | $0.00 | |
| 59400 | Routine obstetric care including antepartum care, vaginal delivery, and postpartum care | 0% | 87 | $0.00 |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | 0% | 547 | $0.00 |
| G9008 | Coordinated care fee, physician coordinated care oversight services | 0% | 88 | $0.00 |
| 80081 | 0% | 965 | $0.00 | |
| 99402 | 0% | 193 | $0.00 | |
| 91301 | 0% | 851 | $0.00 | |
| 88141 | 0% | 698 | $0.00 | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 0% | 78 | $0.00 |
| 99385 | 0% | 192 | $0.00 | |
| H0033 | Oral medication administration, direct observation | 0% | 240 | $0.00 |
| 90696 | 0% | 367 | $0.00 | |
| 90834 | Psychotherapy session, about 45 minutes | 0% | 931 | $0.00 |
| 87430 | 0% | 390 | $0.00 | |
| 1111F | 0% | 292 | $0.00 | |
| 92002 | 0% | 99 | $0.00 | |
| 99386 | 0% | 84 | $0.00 | |
| D0140 | Limited oral evaluation - problem focused | 0% | 180 | $0.00 |
| D1310 | 0% | 66 | $0.00 | |
| 99495 | 0% | 164 | $0.00 | |
| 96156 | 0% | 349 | $0.00 | |
| G8418 | Bmi is documented below normal parameters and a follow-up plan is documented | 0% | 224 | $0.00 |
| H2000 | Comprehensive multidisciplinary evaluation | 0% | 125 | $0.00 |
| 86707 | 0% | 256 | $0.00 | |
| 90744 | 0% | 267 | $0.00 | |
| 87808 | 0% | 323 | $0.00 | |
| 4000F | 0% | 387 | $0.00 | |
| 3075F | 0% | 231 | $0.00 | |
| 86361 | 0% | 1,213 | $0.00 | |
| 86580 | 0% | 1,250 | $0.00 | |
| T1002 | Rn services, up to 15 minutes | 0% | 765 | $0.00 |
| 87046 | 0% | 85 | $0.00 | |
| 84402 | 0% | 481 | $0.00 | |
| 90716 | 0% | 252 | $0.00 | |
| 0011A | 0% | 687 | $0.00 | |
| 84154 | 0% | 81 | $0.00 | |
| T1004 | Services of a qualified nursing aide, up to 15 minutes | 0% | 967 | $0.00 |
| 84132 | 0% | 40 | $0.00 | |
| 86880 | 0% | 15 | $0.00 | |
| 92082 | 0% | 185 | $0.00 | |
| 84270 | 0% | 29 | $0.00 | |
| 99403 | 0% | 296 | $0.00 | |
| 87350 | 0% | 257 | $0.00 | |
| 2001F | 0% | 119 | $0.00 | |
| 90620 | 0% | 173 | $0.00 | |
| H0002 | Behavioral health screening to determine eligibility for admission to treatment program | 0% | 304 | $0.00 |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 0% | 87 | $0.00 |
| 3079F | 0% | 423 | $0.00 | |
| 90647 | 0% | 59 | $0.00 | |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | 0% | 44 | $0.00 |
| 83014 | 0% | 37 | $0.00 | |
| 84144 | 0% | 42 | $0.00 | |
| D1330 | 0% | 66 | $0.00 | |
| J7611 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg | 0% | 16 | $0.00 |
| 3072F | 0% | 34 | $0.00 | |
| 86255 | 0% | 25 | $0.00 | |
| 87625 | 0% | 12 | $0.00 | |
| 0012A | 0% | 688 | $0.00 | |
| 2010F | 0% | 31 | $0.00 | |
| 0710 | 0% | 45 | $0.00 | |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | 0% | 32 | $0.00 |
| G8420 | Bmi is documented within normal parameters and no follow-up plan is required | 0% | 197 | $0.00 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 0% | 31 | $0.00 |
| 90674 | 0% | 231 | $0.00 | |
| 90656 | 0% | 29 | $0.00 | |
| 86777 | 0% | 28 | $0.00 | |
| 1034F | 0% | 166 | $0.00 | |
| 84478 | 0% | 45 | $0.00 | |
| 1125F | 0% | 76 | $0.00 | |
| 99412 | 0% | 57 | $0.00 | |
| S9452 | Nutrition classes, non-physician provider, per session | 0% | 75 | $0.00 |
| 2000F | 0% | 42 | $0.00 | |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | 0% | 57 | $0.00 |
| 94010 | 0% | 149 | $0.00 | |
| 3080F | 0% | 79 | $0.00 | |
| 3351F | 0% | 53 | $0.00 | |
| J1815 | Injection, insulin, per 5 units | 0% | 17 | $0.00 |
| 85660 | 0% | 47 | $0.00 | |
| 87486 | 0% | 12 | $0.00 | |
| 99429 | 0% | 202 | $0.00 | |
| S8110 | Peak expiratory flow rate (physician services) | 0% | 50 | $0.00 |
| B4160 | Enteral formula, for pediatrics, nutritionally complete calorically dense (equal to or greater than 0.7 kcal/ml) with intact nutrients, includes proteins, fats, carbohydrates, vitamins and minerals, may include fiber, administered through an enteral feeding tube, 100 calories = 1 unit | 0% | 25 | $0.00 |
| 86812 | 0% | 12 | $0.00 | |
| 0031A | 0% | 48 | $0.00 | |
| 99383 | 0% | 34 | $0.00 | |
| 90792 | Psychiatric diagnostic evaluation with medical services | 0% | 16 | $0.00 |
| 87529 | 0% | 14 | $0.00 | |
| 92227 | 0% | 17 | $0.00 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | 0% | 42 | $0.00 |
| G8433 | Screening for depression not completed, documented patient or medical reason | 0% | 12 | $0.00 |
| 87490 | 0% | 13 | $0.00 | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 0% | 12 | $0.00 |
| 87650 | 0% | 13 | $0.00 | |
| 3014F | 0% | 14 | $0.00 | |
| 83520 | 0% | 12 | $0.00 | |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | 0% | 15 | $0.00 |
| V2100 | Sphere, single vision, plano to plus or minus 4.00, per lens | 0% | 12 | $0.00 |
| 99606 | 0% | 13 | $0.00 | |
| 4086F | 0% | 12 | $0.00 | |
| 87181 | 0% | 13 | $0.00 | |
| 86141 | 0% | 14 | $0.00 | |
| G0471 | Collection of venous blood by venipuncture or urine sample by catheterization from an individual in a skilled nursing facility (snf) or by a laboratory on behalf of a home health agency (hha) | 0% | 20 | $0.00 |
| 87581 | 0% | 12 | $0.00 | |
| G0008 | Administration of influenza virus vaccine | 0% | 13 | $0.00 |
| S9446 | Patient education, not otherwise classified, non-physician provider, group, per session | 0% | 21 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialDEAKTOR, LINDA (DIRECTOR OF MEDICAL AFFAIRS)
| Provider | Location | Paid |
|---|---|---|
| Global Care Medical Group Ipa | Woodland Hills, CA | $1.86M |
| Bella Vista Medical Group Ipa | Woodland Hills, CA | $108K |
| Mission Community Ipa Medical Group | Woodland Hills, CA | $19K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.